Create a Better Future with Isaiah

About us

以賽亞資本專注於產業最新技術項目，致力於和創業家共創更美好的未來。

From Start-up to Grown-up

我們的團隊成員在全球各商業領域紮根數十年，
對新創公司如何成為世界級領導型團隊有獨特的見解。

We understand your needs

我們的團隊包括全球企業的領導者、科技、生技、財務和營運等專業人士，
過往創辦者和經營者的經驗，我們願意陪伴且明白建立企業並不是一個線性的旅程。

We Invest in breakthrough technologies

我們尋找能重新定義產業、塑造未來、
為社會進步做出貢獻的有遠見的企業家和開創性的想法，並深入支持我們投資的每個團隊。

+SCROLL

Principle

Integrity

誠信是以賽亞資本最重視的資產與原則，也是我們建立成功投資組合和關係之基石，我們深知只有透過誠實、透明和負責任的合作，才能在投資領域建立長遠的信任關係。
Dare to dream

以賽亞資本期許能夠培育更多有想法的人才，並在他們往夢想的旅途上傾注一臂之力。
Respect and Trust

以賽亞資本尊重所有人獨特的意見和想法，作為投資人，我們給予被投資團隊相對大的發揮空間，我們相信真正的成功是雙贏不是獲取個人利益。
Cooperation

在以賽亞資本的理念中，合作不僅是投資和回報，更是持久的夥伴關係，是創造持久的價值、理想、承諾並共同成長。

Our Team

Eric Tseng

Mr. Tseng is the Founder and CEO of Isaiah Research, bringing over 20 years of industry experience. Isaiah Research is recognized as a leading technology research firm in Asia, specializing in semiconductor chips, display panels, smartphone supply chains, and critical components. With clients including Fortune 500 companies like Google, Samsung, Hitachi, JPMorgan, etc, Isaiah Research provides cutting-edge insights into industry trends, value chain dynamics, and competitive analysis. They tailor strategic consulting services to meet client needs, assisting in management and operational decision-making.

As CEO of Isaiah Research, he leads a high-performing business development team. His strategic thinking and creative problem-solving skills play a crucial role in cultivating strong relationships and driving organizational growth and profitability. Eric previously held key positions in procurement departments at Foxconn and HP. His extensive experience in market trend forecasting provides valuable insights to clients, helping them make informed decisions and maintain competitive advantages. Eric holds an MBA from the University of Southern California.
Daniel Shih
Mr. Shih brings over 45 years of experience from major multinational and private companies in business strategy, sales & marketing, and operations. Currently, he serves as Vice Chairman of LionRock Capital Hong Kong, an independent non-executive director at Jung Shingles Wire Industrial Co (TW.1617) and Global Advisor at TrustBridge Foundation, a Swiss-based NGO Foundation.

Career Background
1. Senior Advisor of Viva China (HKEX: 8032)
2. Deputy Chairman of Stella International Holdings (HKSE: 1836)
3. Chairman and GM of Beverages Business Unit, PepsiCo (China) Investment Company
4. President of Motorola (China) Electronics Company
5. Vice President of Government and Public Sector, Asia Pacific, IBM
6. CEO, North Asia of Ernst & Young Global Client Consulting
7. Vice President of Asia Pacific, General Electric (GE)
Board Experience
1. Independent, Non-Executive Board member of Archer-Daniels-Midland Company (NYSE: ADM) and Member of its Nominating/ Corporate Governance and Compensation/ Succession committees
2. China Medicine Corp. (NASDAQ：CHME) Independent Director, Audit Committee, Compensation Committee
3. Independent Non-Executive Director, Audit Committee, Compensation Committee of Sintek Photronic Corp (TPE: 3049)
4. Independent, Non-Executive Board member of Stella International Holdings (HKSE: 1836)
Johnny Chen
Mr. Chen is a senior management executive with over 30 years of multinational, corporate, and board-level experience, specializing in financial and professional services in the Asia Pacific region. Currently, he serves as Vice Chairman of LionRock Capital Hong Kong. He is also a certified public accountant in the United States.

Career Background
1. Senior advisor to Chairman, Viva China Holdings Limited (HKEX: 8032) & LI-NING (China) Sports Goods Co., Ltd. (HKEX: 2331)
2. Director of Asia-Pacific and Chairman of China, Zurich Insurance Group
3. Partner and Managing Partner of Beijing Office, PwC
4. Partner and General Manager of Beijing Office, KPMG
Board Experience
1. Board Director, Clarks
2. Independent Non-Executive Director, China Travel Int’l Investment Hong Kong (308:HK)
3. Independent Non-Executive Director, Uni-President China Holdings (220:HK)
4. Independent Non-Executive Director, Alibaba Pictures Group (1060:HK)
5. Independent Non-Executive Director, Stella International Holdings (1836:HK)
6. Independent Non-Executive Director, China Dongxiang (Group) (3818:HK)
7. Industry Board Member, The Capital Group
8. Independent Non-Executive Director, Viva China Holdings Limited (8032:HK)
9. Non-Executive Director, New China Life Insurance Co. (1336:HK)
Sabrina Li

Ms. Sabrina Li has a professional background in finance, accounting, and entrepreneurship, coupled with extensive workplace experience. She founded Flexiblejobs, specializing in job placement for both businesses and individuals. Ms. Li also serves as a career development mentor for the Finance Department of the Dream House Education Foundation, aiding in career planning and growth. Her previous roles include positions as Capital Markets Manager at TaiShin Securities Co.,Ltd (Member of TaiShin Financial Holding), Deloitte Taiwan, and CFO at In-Creative Corporation, providing her with comprehensive knowledge spanning investment operations to overall financial management in startup ventures. Ms. Li graduated from National Chengchi University with a degree in accounting and holds a Master's in Finance a from National Taiwan University.
Stella Hong

Stella Hong possesses extensive professional experience and profound expertise, focusing on the IPO process, risk management, and internal audit within startup companies. Her career background includes service at PwC Taiwan, where she gained familiarity and mastery in financial reporting, audit procedures, and corporate governance practices. This experience not only solidified her accounting proficiency but also cultivated her deep insights into corporate oversight and risk control. Currently serving at Isaiah Capital, she focuses on financial evaluation and post-investment management. Stella holds a degree in Economics from National Taiwan University.
Lauren Chen

Lauren Chen specializes in pharmaceutical development, medical devices, and investment. She has a solid foundation in these fields, with a good understanding of various stages of drug development and market trends. Currently serving at Isaiah Capital, Lauren focuses on analyzing investment opportunities, executing thorough due diligence, and offering essential support to the deal team. Lauren holds a Master’s degree in Pharmaceutical Science from National Taiwan University.